PetIQ, Inc. (PETQ)
- Previous Close
16.03 - Open
15.95 - Bid 16.25 x 100
- Ask 16.30 x 100
- Day's Range
15.95 - 16.41 - 52 Week Range
11.26 - 22.98 - Volume
147,964 - Avg. Volume
307,432 - Market Cap (intraday)
479.142M - Beta (5Y Monthly) 1.67
- PE Ratio (TTM)
232.57 - EPS (TTM)
0.07 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
29.00
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.
petiq.com1,121
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PETQ
Performance Overview: PETQ
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PETQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PETQ
Valuation Measures
Market Cap
468.07M
Enterprise Value
820.01M
Trailing P/E
229.00
Forward P/E
10.98
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.43
Price/Book (mrq)
2.12
Enterprise Value/Revenue
0.74
Enterprise Value/EBITDA
10.07
Financial Highlights
Profitability and Income Statement
Profit Margin
0.19%
Return on Assets (ttm)
4.00%
Return on Equity (ttm)
1.17%
Revenue (ttm)
1.1B
Net Income Avi to Common (ttm)
2.13M
Diluted EPS (ttm)
0.07
Balance Sheet and Cash Flow
Total Cash (mrq)
116.37M
Total Debt/Equity (mrq)
210.00%
Levered Free Cash Flow (ttm)
40.02M
Research Analysis: PETQ
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell